Marshall Wace, LLP Nevro Corp Transaction History

Marshall Wace, LLP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$22.62 - $39.32 $1.75 Million - $3.05 Million	-77,539 Reduced 70.89%	31,842 $809,000
Q1 2023 May 15, 2023	BUY	$30.17 - $41.11 $223,831 - $304,995	7,419 Added 7.28%	109,381 $3.95 Million
Q4 2022 Feb 14, 2023	SELL	$36.43 - $49.4 $3.07 Million - $4.17 Million	-84,349 Reduced 45.27%	101,962 $4.04 Million
Q3 2022 Nov 14, 2022	SELL	$40.66 - $53.03 $20 Million - $26 Million	-490,779 Reduced 72.48%	186,311 $8.68 Million
Q2 2022 Aug 15, 2022	BUY	$40.85 - $77.67 $9 Million - $17.1 Million	220,384 Added 48.26%	677,090 $29.7 Million
Q1 2022 May 16, 2022	BUY	$59.95 - $92.06 $17.7 Million - $27.2 Million	295,914 Added 184.04%	456,706 $33 Million
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $11.3 Million - $17 Million	139,772 Added 664.95%	160,792 $13 Million
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $2.14 Million - $3.5 Million	21,020 New	21,020 $2.45 Million
Q1 2021 May 17, 2021	SELL	$132.81 - $182.18 $1.28 Million - $1.75 Million	-9,630 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$138.17 - $184.34 $1.33 Million - $1.78 Million	9,630 New	9,630 $1.67 Million
Q2 2019 Aug 14, 2019	SELL	$58.04 - $66.99 $349,632 - $403,547	-6,024 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$35.52 - $62.62 $711,074 - $1.25 Million	-20,019 Reduced 76.87%	6,024 $376,000
Q4 2018 Feb 14, 2019	SELL	$35.43 - $56.29 $140,834 - $223,752	-3,975 Reduced 13.24%	26,043 $1.01 Million
Q3 2018 Nov 14, 2018	BUY	$44.22 - $75.47 $1.33 Million - $2.27 Million	30,018 New	30,018 $1.71 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.